These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10213617)

  • 21. Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles.
    Garrigos M; Belehradek J; Mir LM; Orlowski S
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1034-41. PubMed ID: 7902705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane.
    Garrigues A; Escargueil AE; Orlowski S
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10347-52. PubMed ID: 12145328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
    Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
    Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
    Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
    Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved energy coupling of human P-glycoprotein by the glycine 185 to valine mutation.
    Omote H; Figler RA; Polar MK; Al-Shawi MK
    Biochemistry; 2004 Apr; 43(13):3917-28. PubMed ID: 15049699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.
    Ghetie MA; Ghetie V; Vitetta ES
    Clin Cancer Res; 1999 Dec; 5(12):3920-7. PubMed ID: 10632321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
    Romsicki Y; Sharom FJ
    Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the hydrophobic segment of diacylglycerol kinase epsilon.
    Dicu AO; Topham MK; Ottaway L; Epand RM
    Biochemistry; 2007 May; 46(20):6109-17. PubMed ID: 17455907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residue G346 in transmembrane segment six is involved in inter-domain communication in P-glycoprotein.
    Storm J; O'Mara ML; Crowley EH; Peall J; Tieleman DP; Kerr ID; Callaghan R
    Biochemistry; 2007 Sep; 46(35):9899-910. PubMed ID: 17696319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential.
    Alemán C; Annereau JP; Liang XJ; Cardarelli CO; Taylor B; Yin JJ; Aszalos A; Gottesman MM
    Cancer Res; 2003 Jun; 63(12):3084-91. PubMed ID: 12810633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transport of dietary phenethyl isothiocyanate is mediated by multidrug resistance protein 2 but not P-glycoprotein.
    Ji Y; Morris ME
    Biochem Pharmacol; 2005 Aug; 70(4):640-7. PubMed ID: 16002050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane orientation of carboxyl-terminal half P-glycoprotein: topogenesis of transmembrane segments.
    Han ES; Zhang JT
    Eur J Cell Biol; 1999 Sep; 78(9):624-31. PubMed ID: 10535304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reconstitution of drug-stimulated ATPase activity following co-expression of each half of human P-glycoprotein as separate polypeptides.
    Loo TW; Clarke DM
    J Biol Chem; 1994 Mar; 269(10):7750-5. PubMed ID: 7907331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities.
    Loo TW; Clarke DM
    J Biol Chem; 1995 Sep; 270(37):21449-52. PubMed ID: 7665554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates.
    Loo TW; Clarke DM
    J Biol Chem; 1996 Nov; 271(44):27482-7. PubMed ID: 8910331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A "silent" polymorphism in the MDR1 gene changes substrate specificity.
    Kimchi-Sarfaty C; Oh JM; Kim IW; Sauna ZE; Calcagno AM; Ambudkar SV; Gottesman MM
    Science; 2007 Jan; 315(5811):525-8. PubMed ID: 17185560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homology modeling and binding site assessment of the human P-glycoprotein.
    Tarcsay A; Keseru GM
    Future Med Chem; 2011 Mar; 3(3):297-307. PubMed ID: 21446844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.